FOREWORD
Foreword
01 What Role for Fairness in EU Competition Policy and Enforcement?
02 Foreign Investment Control: Trade Protectionism or Reasonable
Control Over a Nation's Critical Industries?
MERGER CONTROL
03 Gun-Jumping and Procedural Compliance
04 HSR Clearance Does Not Provide Immunity from Investigation
or Challenge
05 Mergers and Innovation: A New Theory of Harm?
06 EU Joint Ventures post-Austria Asphalt
07 The DOJ's Evolving Approach to Consent Decrees
CARTELS
08 Artificial Intelligence and Algorithms in Cartel Cases: Risks in
Potential Broad Theories of Harm
COMPLIANCE
09 Antitrust Enforcement Under the Trump Administration
10 An Update on Brexit and (Current) Implications on Trade
11 Vertical Agreements in the Online Sales of Goods
UNILATERAL CONDUCT
12 Abuse of Dominance Concerning Online Platforms
13 Excessive Pricing, 'Pay-For-Delay' and Rebates: A New Era of
Enforcement in the Pharmaceutical Industry
14 The Intel Ruling: A New Dawn?
ANTITRUST LITIGATION
15 Reverse Payment Patent Settlements in the Pharmaceutical Industry:
A Year in Review
16 Antitrust Discovery and International Comity: Limitations to
Document Production
17 United States v. BMI
18 The Winding Road to the Supreme Court: United States v. American
Express Co.
STATE AID
19 Unsteady Foundations: The European Commission's New Approach
to Infrastructure State Aid
20 The European Commission Investigates U.K. Tax Rules
THE ANTITRUST TEAM 110
THOUGHT LEADERSHIP 116
ABOUT SHEARMAN & STERLING 120
2
64
18
78
42
98
48
